Variant report
Variant | nsv970193 |
---|---|
Chromosome Location | chr6:167786364-167805295 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:176)
- CpG islands (count:915)
- Chromatin interactive region (count:0)
- LncRNA region (count:4)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No. | Transcrition factor | Chromosome Location | Cell Line | Cell type | Cell Stage | Matched TF binding sites |
---|---|---|---|---|---|---|
1 | BATF | chr6:167801477-167801674 | GM12878 | blood: | n/a | n/a |
2 | BCL11A | chr6:167799353-167799569 | GM12878 | blood: | n/a | n/a |
3 | BCL11A | chr6:167801917-167802109 | GM12878 | blood: | n/a | n/a |
4 | BCL11A | chr6:167801472-167801775 | GM12878 | blood: | n/a | n/a |
5 | BCL11A | chr6:167801474-167801790 | GM12878 | blood: | n/a | n/a |
6 | BCL11A | chr6:167800632-167800815 | GM12878 | blood: | n/a | n/a |
7 | CBX3 | chr6:167800537-167800803 | K562 | blood: | n/a | n/a |
8 | CTCF | chr6:167789420-167789570 | HEK293 | kidney: | n/a | n/a |
9 | CTCF | chr6:167789440-167789590 | BE2_C | brain: | n/a | n/a |
10 | CTCF | chr6:167789388-167789559 | H1-hESC | embryonic stem cell: | n/a | n/a |
11 | CTCF | chr6:167803421-167803496 | GM10248 | blood: | n/a | n/a |
12 | CTCF | chr6:167789340-167789490 | SK-N-SH_RA | brain: | n/a | n/a |
13 | CTCF | chr6:167789400-167789550 | WERI-Rb-1 | eye: | n/a | n/a |
14 | CTCF | chr6:167802765-167802797 | Lung_OC | lung: | n/a | n/a |
15 | CTCF | chr6:167786760-167786910 | GM12872 | blood: | n/a | n/a |
16 | CTCF | chr6:167789340-167789490 | HA-sp | spinal cord: | n/a | n/a |
17 | CTCF | chr6:167789420-167789570 | WERI-Rb-1 | eye: | n/a | n/a |
18 | CTCF | chr6:167789400-167789550 | HCT-116 | colon: | n/a | n/a |
19 | CTCF | chr6:167789460-167789610 | HEK293 | kidney: | n/a | n/a |
20 | CTCF | chr6:167789357-167789577 | H1-hESC | embryonic stem cell: | n/a | n/a |
21 | CTCF | chr6:167789400-167789550 | Caco-2 | colon: | n/a | n/a |
22 | CTCF | chr6:167789339-167789607 | H1-hESC | embryonic stem cell: | n/a | n/a |
23 | CTCF | chr6:167789460-167789610 | BE2_C | brain: | n/a | n/a |
24 | CTCF | chr6:167789390-167789517 | HepG2 | liver: | n/a | n/a |
25 | CTCF | chr6:167803194-167803223 | H1-hESC | embryonic stem cell: | n/a | n/a |
26 | CTCF | chr6:167789400-167789550 | HepG2 | liver: | n/a | n/a |
27 | CTCF | chr6:167794893-167794943 | GM20000 | blood: | n/a | n/a |
28 | EBF1 | chr6:167800633-167800823 | GM12878 | blood: | n/a | n/a |
29 | EBF1 | chr6:167799317-167799670 | GM12878 | blood: | n/a | n/a |
30 | EBF1 | chr6:167800374-167800567 | GM12878 | blood: | n/a | n/a |
31 | EBF1 | chr6:167801477-167801660 | GM12878 | blood: | n/a | n/a |
32 | EP300 | chr6:167800291-167802181 | GM12878 | blood: | n/a | n/a |
33 | EP300 | chr6:167799221-167799724 | GM12878 | blood: | n/a | n/a |
34 | EP300 | chr6:167799436-167799593 | GM12878 | blood: | n/a | n/a |
35 | EP300 | chr6:167801907-167802072 | GM12878 | blood: | n/a | n/a |
36 | EP300 | chr6:167801483-167801753 | GM12878 | blood: | n/a | n/a |
37 | FOSL2 | chr6:167801435-167801780 | HepG2 | liver: | n/a | n/a |
38 | FOSL2 | chr6:167786539-167787335 | HepG2 | liver: | n/a | n/a |
39 | FOSL2 | chr6:167799343-167799781 | HepG2 | liver: | n/a | n/a |
40 | FOSL2 | chr6:167799990-167802190 | HepG2 | liver: | n/a | n/a |
41 | FOSL2 | chr6:167786167-167786482 | HepG2 | liver: | n/a | n/a |
42 | FOSL2 | chr6:167799201-167799903 | HepG2 | liver: | n/a | n/a |
43 | FOSL2 | chr6:167786546-167787200 | HepG2 | liver: | n/a | n/a |
44 | FOXA1 | chr6:167786783-167787257 | HepG2 | liver: | n/a | n/a |
45 | GATA2 | chr6:167799305-167799604 | K562 | blood: | n/a | n/a |
46 | GATA2 | chr6:167801141-167801746 | K562 | blood: | n/a | n/a |
47 | GATA2 | chr6:167800336-167801088 | K562 | blood: | n/a | n/a |
48 | GATA2 | chr6:167801829-167802081 | K562 | blood: | n/a | n/a |
49 | HEY1 | chr6:167786617-167787274 | HepG2 | liver: | n/a | n/a |
50 | HEY1 | chr6:167786228-167786480 | HepG2 | liver: | n/a | n/a |
No. | Chromosome Location | Cell Line | Cell type | Cell Stage |
---|---|---|---|---|
1 | chr6:167789195-167789245 | HAEpiC | amniotic membrane: | n/a |
2 | chr6:167792181-167792231 | NB4 | blood: | n/a |
3 | chr6:167791114-167791164 | ProgFib | skin: | n/a |
4 | chr6:167786592-167786642 | NH-A | brain: | n/a |
5 | chr6:167794506-167794556 | Hepatocyte | liver: | n/a |
6 | chr6:167797877-167797927 | HL-60 | blood: | n/a |
7 | chr6:167791024-167791074 | PANC-1 | pancreas: | n/a |
8 | chr6:167786592-167786642 | AoSMC | blood vessel: | n/a |
9 | chr6:167791024-167791074 | HRPEpiC | eye: | n/a |
10 | chr6:167786642-167786692 | U87 | brain: | n/a |
11 | chr6:167786592-167786642 | SK-N-MC | brain: | n/a |
12 | chr6:167789539-167789589 | K562 | blood: | n/a |
13 | chr6:167789195-167789245 | AoSMC | blood vessel: | n/a |
14 | chr6:167792181-167792231 | CMK | blood: | n/a |
15 | chr6:167797877-167797927 | ovcar-3 | ovarian: | n/a |
16 | chr6:167791114-167791164 | HEK293 | kidney: | embryo |
17 | chr6:167791114-167791164 | HPAEpiC | pulmonary alveolar: | n/a |
18 | chr6:167791114-167791164 | Hepatocyte | liver: | n/a |
19 | chr6:167794374-167794424 | GM12891 | blood: | n/a |
20 | chr6:167789195-167789245 | PrEC | prostate: | n/a |
21 | chr6:167792181-167792231 | AG04449 | skin: | fetal |
22 | chr6:167791114-167791164 | NHBE | bronchial: | n/a |
23 | chr6:167794506-167794556 | HEK293 | kidney: | embryo |
24 | chr6:167789441-167789491 | HepG2 | liver: | n/a |
25 | chr6:167797877-167797927 | H1-hESC | embryonic stem cell: | embryo |
26 | chr6:167791114-167791164 | Hela-S3 | cervix: | n/a |
27 | chr6:167789195-167789245 | MCF-7 | breast: | n/a |
28 | chr6:167791153-167791203 | GM06990 | blood: | n/a |
29 | chr6:167803413-167803463 | PrEC | prostate: | n/a |
30 | chr6:167791153-167791203 | A549 | lung: | n/a |
31 | chr6:167798410-167798460 | ECC-1 | luminal epithelium: | n/a |
32 | chr6:167791024-167791074 | NH-A | brain: | n/a |
33 | chr6:167803413-167803463 | IMR90 | lung: | fetal |
34 | chr6:167789441-167789491 | NH-A | brain: | n/a |
35 | chr6:167789195-167789245 | HRE | kidney: | n/a |
36 | chr6:167789195-167789245 | HCF | heart: | n/a |
37 | chr6:167786642-167786692 | LNCaP | prostate: | n/a |
38 | chr6:167794374-167794424 | NB4 | blood: | n/a |
39 | chr6:167797877-167797927 | AG04449 | skin: | fetal |
40 | chr6:167791114-167791164 | HL-60 | blood: | n/a |
41 | chr6:167791153-167791203 | HUVEC | blood vessel: | n/a |
42 | chr6:167803413-167803463 | MCF10A-Er-Src | breast: | n/a |
43 | chr6:167789195-167789245 | NH-A | brain: | n/a |
44 | chr6:167791153-167791203 | HRE | kidney: | n/a |
45 | chr6:167792741-167792791 | SK-N-MC | brain: | n/a |
46 | chr6:167789441-167789491 | PFSK-1 | brain: | n/a |
47 | chr6:167794374-167794424 | HUVEC | blood vessel: | n/a |
48 | chr6:167797877-167797927 | A549 | lung: | n/a |
49 | chr6:167798410-167798460 | HUVEC | blood vessel: | n/a |
50 | chr6:167797877-167797927 | HCM | heart: | n/a |
No data |
(count:4 , 50 per page) page:
1
No. | lncRNA name | Chromosome Location | lncRNA alias |
---|---|---|---|
1 | lnc-TCP10-1 | chr6:167787839-167789289 | NONHSAT116097 |
2 | lnc-TTLL2-1 | chr6:167803650-167803969 | XLOC_005541 |
3 | lnc-TCP10-1 | chr6:167786578-167786848 | NONHSAT116097 |
4 | lnc-TTLL2-1 | chr6:167804760-167804979 | XLOC_005541 |
No data |
No data |
Variant related genes | Relation type |
---|---|
TCP10 | TF binding region |
TCP10 | CpG island |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs201963969 | chr6:167786424-167786425 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
2 | rs557173190 | chr6:167786445-167786446 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
3 | rs575397290 | chr6:167786485-167786486 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
4 | rs545875773 | chr6:167786550-167786551 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
5 | rs146852129 | chr6:167786551-167786552 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
6 | rs528196448 | chr6:167786563-167786564 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
7 | rs3798324 | chr6:167786574-167786575 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
8 | rs375517388 | chr6:167786593-167786594 | Enhancers Weak transcription | lncRNA | n/a | Overlapped CNVs | n/a |
9 | rs539816886 | chr6:167786614-167786615 | Enhancers Flanking Active TSS | lncRNA | n/a | Overlapped CNVs | n/a |
10 | rs369340315 | chr6:167786623-167786624 | Enhancers Flanking Active TSS | lncRNA | n/a | Overlapped CNVs | n/a |
11 | rs529524933 | chr6:167786627-167786628 | Enhancers Flanking Active TSS | lncRNA | n/a | Overlapped CNVs | n/a |
12 | rs372467539 | chr6:167786642-167786643 | Enhancers Flanking Active TSS | lncRNA | n/a | Overlapped CNVs | n/a |
13 | rs62428279 | chr6:167786643-167786644 | Enhancers Flanking Active TSS | lncRNA | n/a | Overlapped CNVs | n/a |
14 | rs370446616 | chr6:167786651-167786652 | Enhancers Flanking Active TSS | lncRNA | n/a | Overlapped CNVs | n/a |
15 | rs181671268 | chr6:167786673-167786674 | Enhancers Flanking Active TSS | lncRNA | n/a | Overlapped CNVs | n/a |
16 | rs377499408 | chr6:167786681-167786682 | Enhancers Flanking Active TSS | lncRNA | n/a | Overlapped CNVs | n/a |
17 | rs140649985 | chr6:167786686-167786687 | Enhancers Flanking Active TSS | lncRNA | n/a | Overlapped CNVs | n/a |
18 | rs375831091 | chr6:167786687-167786688 | Enhancers Flanking Active TSS | lncRNA | n/a | Overlapped CNVs | n/a |
19 | rs201083342 | chr6:167786689-167786690 | Enhancers Flanking Active TSS | lncRNA | n/a | Overlapped CNVs | n/a |
20 | rs146321515 | chr6:167786690-167786691 | Enhancers Flanking Active TSS | lncRNA | n/a | Overlapped CNVs | n/a |
21 | rs367938179 | chr6:167786692-167786693 | Enhancers Flanking Active TSS | lncRNA | n/a | Overlapped CNVs | n/a |
22 | rs555781659 | chr6:167786700-167786701 | Enhancers Flanking Active TSS | lncRNA | n/a | Overlapped CNVs | n/a |
23 | rs567690005 | chr6:167786703-167786704 | Enhancers Flanking Active TSS | lncRNA | n/a | Overlapped CNVs | n/a |
24 | rs200717360 | chr6:167786714-167786715 | Enhancers Flanking Active TSS | lncRNA | n/a | Overlapped CNVs | n/a |
25 | rs372144507 | chr6:167786727-167786728 | Enhancers Flanking Active TSS | lncRNA | n/a | Overlapped CNVs | n/a |
26 | rs143094588 | chr6:167786750-167786751 | Enhancers Flanking Active TSS | lncRNA | n/a | Overlapped CNVs | n/a |
27 | rs78500930 | chr6:167786757-167786758 | Enhancers Flanking Active TSS | lncRNA | n/a | Overlapped CNVs | n/a |
28 | rs200948850 | chr6:167786761-167786762 | Enhancers Flanking Active TSS | lncRNA | n/a | Overlapped CNVs | n/a |
29 | rs575502722 | chr6:167786765-167786766 | Enhancers Flanking Active TSS | lncRNA | n/a | Overlapped CNVs | n/a |
30 | rs371810273 | chr6:167786783-167786784 | Enhancers Flanking Active TSS | lncRNA | n/a | Overlapped CNVs | n/a |
31 | rs545630845 | chr6:167786803-167786804 | Enhancers Bivalent Enhancer Flanking Active TSS | lncRNA | n/a | Overlapped CNVs | n/a |
32 | rs557950844 | chr6:167786856-167786857 | Enhancers Bivalent Enhancer Flanking Active TSS | n/a | n/a | Overlapped CNVs | n/a |
33 | rs572819368 | chr6:167786883-167786884 | Enhancers Bivalent Enhancer Flanking Active TSS | n/a | n/a | Overlapped CNVs | n/a |
34 | rs375849186 | chr6:167786884-167786885 | Enhancers Bivalent Enhancer Flanking Active TSS | n/a | n/a | Overlapped CNVs | n/a |
35 | rs539976123 | chr6:167786903-167786904 | Enhancers Bivalent Enhancer Flanking Active TSS | n/a | n/a | Overlapped CNVs | n/a |
36 | rs199709182 | chr6:167786907-167786908 | Enhancers Bivalent Enhancer Flanking Active TSS | n/a | n/a | Overlapped CNVs | n/a |
37 | rs185908678 | chr6:167786926-167786927 | Enhancers Bivalent Enhancer Flanking Active TSS | n/a | n/a | Overlapped CNVs | n/a |
38 | rs528905211 | chr6:167786952-167786953 | Enhancers Bivalent Enhancer Flanking Active TSS | n/a | n/a | Overlapped CNVs | n/a |
39 | rs151165498 | chr6:167786961-167786962 | Enhancers Bivalent Enhancer Flanking Active TSS | n/a | n/a | Overlapped CNVs | n/a |
40 | rs201342351 | chr6:167786963-167786964 | Enhancers Bivalent Enhancer Flanking Active TSS | n/a | n/a | Overlapped CNVs | n/a |
41 | rs533682520 | chr6:167786964-167786965 | Enhancers Bivalent Enhancer Flanking Active TSS | n/a | n/a | Overlapped CNVs | n/a |
42 | rs551655913 | chr6:167786976-167786977 | Enhancers Bivalent Enhancer Flanking Active TSS | n/a | n/a | Overlapped CNVs | n/a |
43 | rs560771466 | chr6:167786981-167786982 | Enhancers Bivalent Enhancer Flanking Active TSS | n/a | n/a | Overlapped CNVs | n/a |
44 | rs527763793 | chr6:167786990-167786991 | Enhancers Bivalent Enhancer Flanking Active TSS | n/a | n/a | Overlapped CNVs | n/a |
45 | rs199865018 | chr6:167786991-167786992 | Enhancers Bivalent Enhancer Flanking Active TSS | n/a | n/a | Overlapped CNVs | n/a |
46 | rs549545456 | chr6:167787019-167787020 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
47 | rs567653975 | chr6:167787068-167787069 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
48 | rs200607106 | chr6:167787079-167787080 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
49 | rs538199609 | chr6:167787170-167787171 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
50 | rs377629713 | chr6:167787201-167787202 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Uveal melanoma | 21693616 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Biliary cancer | 19435499 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Malaria | 21533027 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Ewing''s sarcoma | 17952124 | CNVD |
Biliary cancer | 20360734 | CNVD |
Breast cancer | 20360734 | CNVD |
Coronary artery disease | 20360734 | CNVD |
Crohn''s disease | 20360734 | CNVD |
Hypertension | 20360734 | CNVD |
Rheumatoid arthritis | 20360734 | CNVD |
Type 1 diabetes | 20360734 | CNVD |
Type 2 diabetes | 20360734 | CNVD |
Acute lymphoblastic leukemia | 22237106 | CNVD |
Neuroblastoma | 18923191 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Melanoma | 18172304 | CNVD |
Cancer | 21637783 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
Follicular lymphoma | 19010834 | CNVD |
Non-small cell lung cancer | 21044232 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Breast cancer | 21264507 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Glioblastoma multiforme | 19960244 | CNVD |
Hepatocellular carcinoma | 22174799 | CNVD |
Phyllodes tumor | 17334353 | CNVD |
Breast cancer | 16608533 | CNVD |
Non-small cell lung cancer | 21385341 | CNVD |
Prostate cancer | 16705090 | CNVD |
Adenoid cystic carcinoma | 17372589 | CNVD |
Colorectal cancer | 16272173 | CNVD |
Ependymoma | 16718352 | CNVD |
Gastric cancer | 17908304 | CNVD |
High-proliferative meningiomas | 17937814 | CNVD |
Intracranial tumor | 16823260 | CNVD |
Monoclonal gammopathy of undetermined significance | 17077331 | CNVD |
Basal cell lymphoma | 16317097 | CNVD |
Diffuse large b-cell lymphoma | 16317097 | CNVD |
Breast cancer | 16272173 | CNVD |
Wilms tumour | 21544195 | CNVD |
Acute lymphoblastic leukemia | 20067559 | CNVD |
Congenital diaphragmatic hernia | 21085971 | CNVD |
Malignant melanoma | 18718029 | CNVD |
Acute lymphoblastic leukemia | 17690704 | CNVD |
Breast cancer | 21858162 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Breast cancer | 17603634 | CNVD |
Developmental delay | 19490664 | CNVD |
Burkitt''s lymphoma | 18698080 | CNVD |
Neurodevelopmental disorder | 22521361 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Adenoid cystic carcinoma | 18698036 | CNVD |
head and neck squamous cell carcinoma | 17671120 | CNVD |
Leukemia | 18688285 | CNVD |
T-cell prolymphocytic leukemia | 17713554 | CNVD |
Prostate cancer | 18632612 | CNVD |
Lung cancer | 18438408 | CNVD |
Burkitt''s lymphoma | 19759907 | CNVD |
Esophageal cancer | 21851588 | CNVD |
T-cell acute lymphoblastic leukemia | 18185524 | CNVD |
Breast cancer | 17133270 | CNVD |
Testicular germ cell tumor | 18059402 | CNVD |
Chordoma | 18071362 | CNVD |
Glioblastoma multiforme | 19435819 | CNVD |
Developmental delay | 21147756 | CNVD |
Ovarian cancer | 21720365 | CNVD |
abnormal development | 18461090 | CNVD |
Epilepsy | 22083797 | CNVD |
Myelofibrosis | 22110671 | CNVD |
chordoma | 19801981 | CNVD |
Myxofibrosarcoma | 16751306 | CNVD |
Autism | 17483303 | CNVD |
Acute lymphoblastic leukemia | 21098271 | CNVD |
Acute myeloid leukemia | 19651601 | CNVD |
Sudden cardiac death | 19188705 | CNVD |
Myofibroblastic sarcoma | 19369631 | CNVD |
Non-syndromic sensorineural hearing loss | 17122850 | CNVD |
Non-syndromic sensorineural hearing loss | 19587683 | CNVD |
Non-syndromic sensorineural hearing loss | 21293372 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr6:167785400-167786600 | Weak transcription | Fetal Intestine Small | intestine |
2 | chr6:167785400-167786600 | Weak transcription | HepG2 | liver |
3 | chr6:167786200-167786600 | Weak transcription | Rectal Mucosa Donor 31 | rectum |
4 | chr6:167786400-167786600 | Enhancers | Fetal Intestine Large | intestine |
5 | chr6:167786400-167786600 | Enhancers | Rectal Mucosa Donor 29 | rectum |
6 | chr6:167786600-167787000 | Enhancers | Liver | Liver |
7 | chr6:167786600-167787000 | Enhancers | Duodenum Mucosa | Duodenum |
8 | chr6:167786600-167787000 | Flanking Active TSS | Fetal Intestine Large | intestine |
9 | chr6:167786600-167787000 | Flanking Active TSS | Fetal Intestine Small | intestine |
10 | chr6:167786600-167787000 | Flanking Active TSS | Rectal Mucosa Donor 29 | rectum |
11 | chr6:167786600-167787000 | Enhancers | Rectal Mucosa Donor 31 | rectum |
12 | chr6:167786600-167787000 | Enhancers | Stomach Mucosa | stomach |
13 | chr6:167786600-167787000 | Flanking Active TSS | HepG2 | liver |
14 | chr6:167786800-167787000 | Bivalent Enhancer | Fetal Adrenal Gland | Adrenal Gland |
15 | chr6:167787000-167787400 | Enhancers | Fetal Intestine Large | intestine |
16 | chr6:167787000-167787600 | Enhancers | HepG2 | liver |
17 | chr6:167787000-167788000 | Enhancers | Fetal Intestine Small | intestine |
18 | chr6:167787600-167791200 | Weak transcription | HepG2 | liver |
19 | chr6:167791000-167791200 | Bivalent Enhancer | Fetal Muscle Trunk | muscle |
20 | chr6:167791200-167791400 | Enhancers | HepG2 | liver |
21 | chr6:167791400-167791600 | Bivalent Enhancer | HepG2 | liver |
22 | chr6:167796200-167796400 | Bivalent Enhancer | HepG2 | liver |